SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NSIX -- Neuromedical Systems, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sigmund who wrote (24)10/4/1997 2:01:00 PM
From: ajulius   of 137
 
CYTC is not in the same market. It does not handle rescreening but rather a product which improves the pap smear. NPTH handles a rescreening system as does NSIX though differences remain in the two systems. There is a host of other competiton as well and others have systems in development.

I am bullish on NSIX and I believe that it will be the system of choice based on the system itself, and based on the scientific community which likes NSIX the best. Even in the most recent press release, the medical community, not NSIX was pushing for rescreening using Papnet for the poor. NSIX had little to do with it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext